A long term study of low concentration guanethidine and adrenaline therapy in glaucoma

ISSN:
1573-2630
Keywords:
glaucoma ; intra-ocular pressure ; guanethidine ; adrenaline
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract A long term study was undertaken to evaluate the efficacy of combined guanethidine (1%) and adrenaline (0.05–0.5%) therapy in controlling intra-ocular pressure in 89 patients with chronic open angle glaucoma, in whom ocular tensions proved difficult to control on miotics and/or carbonic anhydrase inhibitors. Visual acuity, fields of vision, applanation tension, size of the pupil, anterior chamber depth and gonioscopic examination of the angle were recorded before and during treatment. The follow-up extended over a period of 12 to 42 months, the mean being 28 months. The combined therapy was found to lower the intra-ocular pressure significantly in a large number of patients and the most potent combination was guanethidine 1% and adrenaline 1/4% and the average fall of intraocular pressure with the combined therapy was around 8 mm Hg. Intolerance to the combined preparation was noticed in three patients during a period of 12–18 months with the symptoms of sore eyes, conjunctival hyperaemia and lid irritation of such severity that the treatment had to be withdrawn. Resistance to treatment developed in four patients during a period of 12–36 months and treatment had to be changed. Addition to guanethidine (1%) and adrenaline up to 1/4% to pilocarpine therapy (2–4%) in eyes with narrow angles did not result in any appreciable change of the width of the angle, the size of the pupil and the depth of the anterior chamber.
Type of Medium:
Electronic Resource
URL:
_version_ 1798296655409184768
autor Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
autorsonst Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
book_url http://dx.doi.org/10.1007/BF00136209
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM194449556
issn 1573-2630
journal_name International ophthalmology
materialart 1
notes Abstract A long term study was undertaken to evaluate the efficacy of combined guanethidine (1%) and adrenaline (0.05–0.5%) therapy in controlling intra-ocular pressure in 89 patients with chronic open angle glaucoma, in whom ocular tensions proved difficult to control on miotics and/or carbonic anhydrase inhibitors. Visual acuity, fields of vision, applanation tension, size of the pupil, anterior chamber depth and gonioscopic examination of the angle were recorded before and during treatment. The follow-up extended over a period of 12 to 42 months, the mean being 28 months. The combined therapy was found to lower the intra-ocular pressure significantly in a large number of patients and the most potent combination was guanethidine 1% and adrenaline 1/4% and the average fall of intraocular pressure with the combined therapy was around 8 mm Hg. Intolerance to the combined preparation was noticed in three patients during a period of 12–18 months with the symptoms of sore eyes, conjunctival hyperaemia and lid irritation of such severity that the treatment had to be withdrawn. Resistance to treatment developed in four patients during a period of 12–36 months and treatment had to be changed. Addition to guanethidine (1%) and adrenaline up to 1/4% to pilocarpine therapy (2–4%) in eyes with narrow angles did not result in any appreciable change of the width of the angle, the size of the pupil and the depth of the anterior chamber.
package_name Springer
publikationsjahr_anzeige 1980
publikationsjahr_facette 1980
publikationsjahr_intervall 8019:1980-1984
publikationsjahr_sort 1980
publisher Springer
reference 3 (1980), S. 19-23
schlagwort glaucoma
intra-ocular pressure
guanethidine
adrenaline
search_space articles
shingle_author_1 Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
shingle_author_2 Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
shingle_author_3 Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
shingle_author_4 Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
shingle_catch_all_1 Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
glaucoma
intra-ocular pressure
guanethidine
adrenaline
glaucoma
intra-ocular pressure
guanethidine
adrenaline
Abstract A long term study was undertaken to evaluate the efficacy of combined guanethidine (1%) and adrenaline (0.05–0.5%) therapy in controlling intra-ocular pressure in 89 patients with chronic open angle glaucoma, in whom ocular tensions proved difficult to control on miotics and/or carbonic anhydrase inhibitors. Visual acuity, fields of vision, applanation tension, size of the pupil, anterior chamber depth and gonioscopic examination of the angle were recorded before and during treatment. The follow-up extended over a period of 12 to 42 months, the mean being 28 months. The combined therapy was found to lower the intra-ocular pressure significantly in a large number of patients and the most potent combination was guanethidine 1% and adrenaline 1/4% and the average fall of intraocular pressure with the combined therapy was around 8 mm Hg. Intolerance to the combined preparation was noticed in three patients during a period of 12–18 months with the symptoms of sore eyes, conjunctival hyperaemia and lid irritation of such severity that the treatment had to be withdrawn. Resistance to treatment developed in four patients during a period of 12–36 months and treatment had to be changed. Addition to guanethidine (1%) and adrenaline up to 1/4% to pilocarpine therapy (2–4%) in eyes with narrow angles did not result in any appreciable change of the width of the angle, the size of the pupil and the depth of the anterior chamber.
1573-2630
15732630
Springer
shingle_catch_all_2 Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
glaucoma
intra-ocular pressure
guanethidine
adrenaline
glaucoma
intra-ocular pressure
guanethidine
adrenaline
Abstract A long term study was undertaken to evaluate the efficacy of combined guanethidine (1%) and adrenaline (0.05–0.5%) therapy in controlling intra-ocular pressure in 89 patients with chronic open angle glaucoma, in whom ocular tensions proved difficult to control on miotics and/or carbonic anhydrase inhibitors. Visual acuity, fields of vision, applanation tension, size of the pupil, anterior chamber depth and gonioscopic examination of the angle were recorded before and during treatment. The follow-up extended over a period of 12 to 42 months, the mean being 28 months. The combined therapy was found to lower the intra-ocular pressure significantly in a large number of patients and the most potent combination was guanethidine 1% and adrenaline 1/4% and the average fall of intraocular pressure with the combined therapy was around 8 mm Hg. Intolerance to the combined preparation was noticed in three patients during a period of 12–18 months with the symptoms of sore eyes, conjunctival hyperaemia and lid irritation of such severity that the treatment had to be withdrawn. Resistance to treatment developed in four patients during a period of 12–36 months and treatment had to be changed. Addition to guanethidine (1%) and adrenaline up to 1/4% to pilocarpine therapy (2–4%) in eyes with narrow angles did not result in any appreciable change of the width of the angle, the size of the pupil and the depth of the anterior chamber.
1573-2630
15732630
Springer
shingle_catch_all_3 Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
glaucoma
intra-ocular pressure
guanethidine
adrenaline
glaucoma
intra-ocular pressure
guanethidine
adrenaline
Abstract A long term study was undertaken to evaluate the efficacy of combined guanethidine (1%) and adrenaline (0.05–0.5%) therapy in controlling intra-ocular pressure in 89 patients with chronic open angle glaucoma, in whom ocular tensions proved difficult to control on miotics and/or carbonic anhydrase inhibitors. Visual acuity, fields of vision, applanation tension, size of the pupil, anterior chamber depth and gonioscopic examination of the angle were recorded before and during treatment. The follow-up extended over a period of 12 to 42 months, the mean being 28 months. The combined therapy was found to lower the intra-ocular pressure significantly in a large number of patients and the most potent combination was guanethidine 1% and adrenaline 1/4% and the average fall of intraocular pressure with the combined therapy was around 8 mm Hg. Intolerance to the combined preparation was noticed in three patients during a period of 12–18 months with the symptoms of sore eyes, conjunctival hyperaemia and lid irritation of such severity that the treatment had to be withdrawn. Resistance to treatment developed in four patients during a period of 12–36 months and treatment had to be changed. Addition to guanethidine (1%) and adrenaline up to 1/4% to pilocarpine therapy (2–4%) in eyes with narrow angles did not result in any appreciable change of the width of the angle, the size of the pupil and the depth of the anterior chamber.
1573-2630
15732630
Springer
shingle_catch_all_4 Nagasubramanian, S.
Gloster, J.
Poinoosawmy, D.
Watkins, R.
A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
glaucoma
intra-ocular pressure
guanethidine
adrenaline
glaucoma
intra-ocular pressure
guanethidine
adrenaline
Abstract A long term study was undertaken to evaluate the efficacy of combined guanethidine (1%) and adrenaline (0.05–0.5%) therapy in controlling intra-ocular pressure in 89 patients with chronic open angle glaucoma, in whom ocular tensions proved difficult to control on miotics and/or carbonic anhydrase inhibitors. Visual acuity, fields of vision, applanation tension, size of the pupil, anterior chamber depth and gonioscopic examination of the angle were recorded before and during treatment. The follow-up extended over a period of 12 to 42 months, the mean being 28 months. The combined therapy was found to lower the intra-ocular pressure significantly in a large number of patients and the most potent combination was guanethidine 1% and adrenaline 1/4% and the average fall of intraocular pressure with the combined therapy was around 8 mm Hg. Intolerance to the combined preparation was noticed in three patients during a period of 12–18 months with the symptoms of sore eyes, conjunctival hyperaemia and lid irritation of such severity that the treatment had to be withdrawn. Resistance to treatment developed in four patients during a period of 12–36 months and treatment had to be changed. Addition to guanethidine (1%) and adrenaline up to 1/4% to pilocarpine therapy (2–4%) in eyes with narrow angles did not result in any appreciable change of the width of the angle, the size of the pupil and the depth of the anterior chamber.
1573-2630
15732630
Springer
shingle_title_1 A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
shingle_title_2 A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
shingle_title_3 A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
shingle_title_4 A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:55:33.145Z
titel A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
titel_suche A long term study of low concentration guanethidine and adrenaline therapy in glaucoma
topic WW-YZ
uid nat_lic_papers_NLM194449556